National Health Investors (NYSE:NHI) Price Target Cut to $72.00 by Analysts at Truist Financial

National Health Investors (NYSE:NHI) had its price objective cut by Truist Financial from $78.00 to $72.00 in a research note released on Monday,Benzinga reports. They currently have a hold rating on the real estate investment trust’s stock.

A number of other brokerages have also commented on NHI. StockNews.com lowered National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, October 15th. Wells Fargo & Company downgraded shares of National Health Investors from an “overweight” rating to an “equal weight” rating and lifted their target price for the stock from $81.00 to $86.00 in a research report on Tuesday, October 1st. Finally, Bank of America began coverage on shares of National Health Investors in a research report on Tuesday, September 24th. They issued a “buy” rating and a $92.00 price target for the company. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $75.33.

National Health Investors Price Performance

NHI stock opened at $69.06 on Monday. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92. The firm has a market cap of $3.14 billion, a P/E ratio of 23.73, a P/E/G ratio of 4.86 and a beta of 1.04. The company’s 50-day moving average price is $76.02 and its two-hundred day moving average price is $75.66. National Health Investors has a 12 month low of $51.59 and a 12 month high of $86.13.

National Health Investors (NYSE:NHI) last released its quarterly earnings data on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.42). The business had revenue of $63.32 million during the quarter, compared to analyst estimates of $67.93 million. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The business’s quarterly revenue was up 1.7% compared to the same quarter last year. During the same period last year, the business earned $1.08 earnings per share. On average, analysts anticipate that National Health Investors will post 4.42 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be paid a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a yield of 5.21%. The ex-dividend date is Tuesday, December 31st. National Health Investors’s dividend payout ratio is presently 123.71%.

Institutional Trading of National Health Investors

A number of institutional investors have recently bought and sold shares of the company. Lee Danner & Bass Inc. bought a new stake in shares of National Health Investors during the 2nd quarter valued at about $5,089,000. International Assets Investment Management LLC acquired a new stake in shares of National Health Investors during the 2nd quarter worth approximately $36,000. Van ECK Associates Corp increased its stake in shares of National Health Investors by 6.9% in the 2nd quarter. Van ECK Associates Corp now owns 6,404 shares of the real estate investment trust’s stock valued at $434,000 after acquiring an additional 416 shares in the last quarter. Rhumbline Advisers increased its stake in shares of National Health Investors by 2.2% in the 2nd quarter. Rhumbline Advisers now owns 81,910 shares of the real estate investment trust’s stock valued at $5,548,000 after acquiring an additional 1,727 shares in the last quarter. Finally, Victory Capital Management Inc. lifted its position in shares of National Health Investors by 334.1% during the 2nd quarter. Victory Capital Management Inc. now owns 23,666 shares of the real estate investment trust’s stock valued at $1,603,000 after acquiring an additional 18,214 shares during the period. Institutional investors own 62.51% of the company’s stock.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.